Skip to main content
    E

    Enovis Corp (ENOV)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $27.93
    +0.25 (+0.90%)

    Market Cap: $1.60B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Enovis Corp (ENOV) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Enovis reported revenue of $2.25B for the fiscal year ended Dec 31, 2025, up 6.7% from the year before. That year, net income was -$1.18B with a net margin of -52.7%, operating cash flow was $217.29M and free cash flow was $19.92M. The quarter ended Sep 30, 2026 had revenue of $558.73M and net income of $3.42M.

    Revenue and Margins

    The operating margin was -50.0% in the fiscal year ended Dec 2025, the lowest of the 10 years shown. Over the 9 years to Dec 2025, revenue fell from $3.19B, a compound annual decline of 3.8%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$2.25B+6.7%59.8%-50.0%-52.7%
    Dec 2024$2.11B+23.5%56.0%-36.8%-39.1%
    Dec 2023$1.71B+9.2%58.0%-3.8%-1.9%
    Dec 2022$1.56B+9.6%55.6%-4.6%-0.8%
    Dec 2021$1.43B+27.3%54.5%-4.4%5.3%
    Dec 2020$1.12B-66.3%53.9%-5.9%4.1%
    Dec 2019$3.33B+51.7%42.1%6.1%-15.5%
    Dec 2018$2.19B+13.2%33.3%6.9%7.0%
    Dec 2017$1.94B-39.2%34.7%7.0%8.7%
    Dec 2016$3.19BN/A31.2%7.4%4.6%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, net income turned positive after a loss in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$2.25B$2.11B$1.71B$1.56B$1.43B$1.12B$3.33B$2.19B$1.94B$3.19B
    Cost of revenue$902.79M$926.87M$716.42M$693.72M$648.51M$517.06M$1.93B$1.46B$1.27B$2.19B
    Gross profit$1.35B$1.18B$990.78M$869.38M$777.67M$603.64M$1.40B$729.38M$671.58M$992.38M
    Research and development$120.33M$91.30M$75.33M$60.83M$49.09M$34.27M$0$0$0$0
    Operating income-$1.12B-$775.72M-$65.71M-$71.18M-$62.80M-$66.18M$203.61M$151.54M$135.60M$236.85M
    Net income-$1.18B-$824.82M-$32.73M-$11.76M$76.28M$45.77M-$517.15M$154.47M$169.51M$145.19M
    EBITDA-$830.22M-$481.03M$177.06M$159.42M$200.12M$180.05M$406.02M$293.45M$220.87M$374.02M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$558.73M$582.78M$589.15M$575.76M$548.91M$564.54M$558.83M$560.98M$505.22M$525.16M$516.27M$455.02M
    Gross profit$339.85M$359.25M$365.49M$349.42M$328.91M$334.70M$332.23M$307.52M$286.46M$288.88M$297.90M$264.39M
    Operating income$3.38M$17.41M$6.53M-$502.18M-$558.49M-$16.80M-$46.77M-$664.75M-$31.74M-$44.22M-$35.01M-$5.75M
    Net income$3.42M-$1.04M-$8.45M-$520.45M-$570.91M-$36.55M-$55.70M-$703.20M-$31.26M-$18.51M-$71.84M$3.08M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $1.30B exceeded cash and equivalents by $1.26B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$3.83B$4.72B$4.51B$4.27B$8.52B$7.35B$7.39B$6.62B$6.71B$6.34B
    Current assets$1.21B$1.15B$896.52M$795.02M$2.30B$1.36B$1.40B$1.96B$2.07B$1.74B
    Cash and equivalents$36.39M$48.17M$36.19M$24.30M$680.25M$97.07M$109.63M$77.15M$262.02M$208.81M
    Total liabilities$2.34B$2.15B$1.09B$823.45M$3.85B$3.76B$3.90B$3.14B$2.98B$3.25B
    Short-term debt$35.00M$20.03M$0$219.28M$7.70M$27.07M$27.64M$5.02M$5.77M$5.41M
    Long-term debt$1.26B$1.31B$466.16M$40.00M$2.08B$2.20B$2.28B$1.19B$1.06B$1.29B
    Shareholder equity$1.49B$2.56B$3.42B$3.45B$4.62B$3.54B$3.44B$3.27B$3.50B$2.90B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$3.74B$3.77B$3.83B$3.83B$4.43B$5.02B$4.88B$4.72B$5.55B$5.44B$5.48B$4.51B
    Total liabilities$2.24B$2.29B$2.35B$2.34B$2.41B$2.44B$2.25B$2.15B$2.22B$2.15B$2.17B$1.09B
    Cash and equivalents$13.04M$12.56M$33.13M$36.39M$33.62M$44.07M$38.46M$48.17M$35.42M$35.00M$66.27M$36.19M
    Shareholder equity$1.49B$1.48B$1.48B$1.49B$2.02B$2.58B$2.62B$2.56B$3.33B$3.29B$3.31B$3.42B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 9.2% of operating cash flow. Share repurchases came to 17.6% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$217.29M$113.50M$134.99M-$55.86M$356.10M$301.94M$130.95M$226.37M$218.77M$246.97M
    Capital expenditures$197.38M$180.71M$122.22M$105.45M$104.24M$114.78M$125.40M$69.65M$68.77M$63.25M
    Free cash flow$19.92M-$67.21M$12.77M-$161.31M$251.86M$187.15M$5.55M$156.72M$150.00M$183.72M
    Dividends paidN/AN/AN/AN/AN/AN/A$93.50M$0$0$896.74M
    Share repurchases$3.50M$4.77M$0$0N/AN/AN/A$200.00M$0$20.81M
    Investing cash flow-$179.37M-$955.47M-$242.47M-$176.39M-$320.48M-$175.08M-$1.63B-$167.85M$89.88M-$81.99M
    Financing cash flow-$52.40M$846.82M$127.80M-$465.13M$584.91M-$131.65M$1.37B-$47.15M-$280.45M-$145.22M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$71.49M$75.03M$23.95M$88.54M$82.58M$47.77M-$1.60M$88.33M$53.56M$7.77M-$36.16M$68.42M
    Capital expenditures$36.51M$43.90M$52.80M$56.25M$53.49M$44.37M$43.26M$53.19M$51.19M$39.41M$36.93M$27.94M
    Free cash flow$34.99M$31.14M-$28.85M$32.29M$29.09M$3.40M-$44.86M$35.14M$2.37M-$31.63M-$73.08M$40.47M
    Last 12 quarters

    Frequently Asked Questions About ENOV

    What is Enovis' annual revenue?

    Enovis reported revenue of $2.25B for the fiscal year ended Dec 31, 2025.

    How fast is Enovis' revenue growing?

    Revenue was up 6.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 12.9%.

    Is Enovis profitable?

    No. Enovis reported net income of -$1.18B for the fiscal year ended Dec 31, 2025, with a net margin of -52.7%.

    How much free cash flow does ENOV generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $217.29M minus capital expenditures of $197.38M produced free cash flow of $19.92M.

    How much debt does Enovis have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $1.26B, short-term debt of $35.00M and cash and equivalents of $36.39M.